There may be ‘good news’ coming for Apple Watch users in the US
The resignation of Masimo’s CEO, Joe Kiani, could resolve its patent dispute with Apple over blood oxygen technology. A leadership change may open doors for a conciliatory approach, potentially leading to the return of the blood oxygen feature in Apple Watch models sold in the US. A licensing agreement or collaboration may soon be on the horizon.